The stock of Acadia Healthcare Company Inc (NASDAQ:ACHC) hit a new 52-week low and has $43.22 target or 7.00% below today’s $46.47 share price. The 6 months bearish chart indicates high risk for the $3.99 billion company. The 1-year low was reported on Oct, 7 by Barchart.com. If the $43.22 price target is reached, the company will be worth $279.30 million less.
The 52-week low event is an important milestone for every stock because it shows very negative momentum and is time when sellers come in. During such technical setups, fundamental investors usually stay away and are careful buying the stock. About 1.31M shares traded hands or 31.19% up from the average. Acadia Healthcare Company Inc (NASDAQ:ACHC) has declined 18.78% since March 4, 2016 and is downtrending. It has underperformed by 26.81% the S&P500.
Analysts await Acadia Healthcare Company Inc (NASDAQ:ACHC) to report earnings on November, 1. They expect $0.67 earnings per share, up 8.06% or $0.05 from last year’s $0.62 per share. ACHC’s profit will be $57.53M for 17.34 P/E if the $0.67 EPS becomes a reality. After $0.73 actual earnings per share reported by Acadia Healthcare Company Inc for the previous quarter, Wall Street now forecasts -8.22% negative EPS growth.
Acadia Healthcare Company Inc (NASDAQ:ACHC) Ratings Coverage
Out of 9 analysts covering Acadia Healthcare (NASDAQ:ACHC), 8 rate it a “Buy”, 0 “Sell”, while 1 “Hold”. This means 89% are positive. Acadia Healthcare has been the topic of 14 analyst reports since August 6, 2015 according to StockzIntelligence Inc. The stock of Acadia Healthcare Company Inc (NASDAQ:ACHC) has “Outperform” rating given on Monday, August 1 by RBC Capital Markets. Cantor Fitzgerald maintained the stock with “Buy” rating in Thursday, August 6 report. Mizuho maintained the shares of ACHC in a report on Thursday, August 6 with “Buy” rating. Zacks upgraded the shares of ACHC in a report on Thursday, August 6 to “Hold” rating. JP Morgan initiated the shares of ACHC in a report on Wednesday, September 16 with “Neutral” rating. The rating was maintained by Mizuho with “Buy” on Friday, April 29. Leerink Swann initiated the stock with “Outperform” rating in Tuesday, September 1 report. The rating was maintained by Robert W. Baird with “Outperform” on Thursday, September 15. The firm has “Overweight” rating given on Monday, February 1 by KeyBanc Capital Markets.
According to Zacks Investment Research, “Acadia Healthcare Company, Inc. provides inpatient behavioral health care services. It provides psychiatric and chemical dependency services, including inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and therapeutic school-based programs. Acadia Healthcare Company, Inc. is headquartered in Franklin, Tennessee.”
Insitutional Activity: The institutional sentiment decreased to 1.25 in 2016 Q2. Its down 0.09, from 1.34 in 2016Q1. The ratio worsened, as 32 funds sold all Acadia Healthcare Company Inc shares owned while 70 reduced positions. 34 funds bought stakes while 94 increased positions. They now own 85.76 million shares or 4.92% more from 81.74 million shares in 2016Q1.
Point72 Asset Limited Partnership holds 0.09% of its portfolio in Acadia Healthcare Company Inc (NASDAQ:ACHC) for 233,300 shares. Granahan Mgmt Inc Ma has 0.61% invested in the company for 304,100 shares. Adage Cap Gru Limited Company holds 0.04% of its portfolio in Acadia Healthcare Company Inc (NASDAQ:ACHC) for 250,000 shares. Benjamin F Edwards Incorporated has invested 0.01% of its portfolio in Acadia Healthcare Company Inc (NASDAQ:ACHC). Renaissance Technology Limited Liability Com accumulated 0.01% or 65,315 shares. Ameriprise Inc has invested 0.01% of its portfolio in Acadia Healthcare Company Inc (NASDAQ:ACHC). Glenmede Com Na holds 855,897 shares or 0.29% of its portfolio. Hap Trading Lc has 0.09% invested in the company for 26,336 shares. Moreover, Suntrust Banks Incorporated has 0% invested in Acadia Healthcare Company Inc (NASDAQ:ACHC) for 4,827 shares. Everpoint Asset Limited Com accumulated 335,000 shares or 0.37% of the stock. Philadelphia Of San Francisco holds 3.78% or 297,100 shares in its portfolio. First Personal Fin Services holds 0.01% or 578 shares in its portfolio. Lord Abbett Limited Liability Corp holds 0.01% or 59,675 shares in its portfolio. Huntington National Bank & Trust has invested 0% of its portfolio in Acadia Healthcare Company Inc (NASDAQ:ACHC). Morgan Stanley accumulated 0% or 28,319 shares.
Insider Transactions: Since August 5, 2016, the stock had 0 buys, and 10 sales for $139.31 million net activity. WAUD REEVE B had sold 1.36M shares worth $66.04M. Another trade for 16,670 shares valued at $905,681 was made by Duckworth David M. on Monday, August 15. WAUD CAPITAL PARTNERS III – L.L.C. also sold $1.55 million worth of Acadia Healthcare Company Inc (NASDAQ:ACHC) on Monday, September 12. $2.81M worth of shares were sold by WAUD CAPITAL PARTNERS II – L.L.C. on Monday, September 12. GOLDBERG RANDALL P also sold $190,044 worth of Acadia Healthcare Company Inc (NASDAQ:ACHC) shares. Fincher Ronald Morgan also sold $462,536 worth of Acadia Healthcare Company Inc (NASDAQ:ACHC) on Monday, August 8.
Another recent and important Acadia Healthcare Company Inc (NASDAQ:ACHC) news was published by Zacks.com which published an article titled: “Acadia Healthcare to Serve FBINAA as Treatment Provider” on September 21, 2016.
ACHC Company Profile
Acadia Healthcare Company, Inc., incorporated on October 24, 2005, is a well-known provider of behavioral healthcare services. The Firm operates in two divisions: U.S. Facilities and U.K. Facilities. The Firm develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities and facilities providing outpatient behavioral healthcare services to serve the behavioral health and recovery needs of communities throughout the United States, the United Kingdom and Puerto Rico. The Firm operates approximately 260 behavioral healthcare facilities with over 9,900 beds in over 40 states, the United Kingdom and Puerto Rico.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.